Hypoxia-induced autophagy: A new player in cancer immunotherapy?

Autophagy

Volumn 8, Issue 4, 2012, Pages 704-706

  Noman, Muhammad Zaeem ^a   Janji, Bassam ^b   Berchem, Guy ^b   Mami Chouaib, Fathia ^a   Chouaib, Salem ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Public Research Centre for Health   (Luxembourg)

Author keywords

Adaptive immunity; Autophagy; Cancer vaccines; Hypoxia

Indexed keywords

AUTOPHAGY PROTEIN 5; BECLIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN; PROTEIN BCL 2; PROTEIN P62; SQSTM1 PROTEIN; STAT3 PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AUTOPHAGY; CANCER IMMUNIZATION; CELL DEATH; CELLULAR IMMUNITY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; EFFECTOR CELL; HUMAN; HYPOXIA; IMMUNOMODULATION; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; MOLECULAR MECHANICS; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SHORT SURVEY; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

EID: 84862277154     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.19572     Document Type: Short Survey

References (0)